Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages

Tsuyoshi Yoshida1, Yasuhiro Tsuda, Dan Takeuchi

  • 1Department of Internal Medicine, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0435, USA.

Cytokine
|April 25, 2006
PubMed

Insights

Glycyrrhizin (GL) inhibits the generation of immunosuppressive alternatively activated macrophages (M2Mphi) in burn patients. This compound blocks neutrophils (PMN-II) from producing key signaling molecules, thereby reducing infection susceptibility.

Area of Science:

  • Immunology
  • Wound Healing
  • Pharmacology

Background:

  • Severe burn injuries increase infection risk due to suppressed antibacterial responses.
  • Alternatively activated macrophages (M2Mphi) and immunosuppressive neutrophils (PMN-II) are implicated in burn-induced immune suppression.
  • PMN-II are known to induce M2Mphi generation.

Purpose of the Study:

  • To investigate the inhibitory effect of glycyrrhizin (GL) on M2Mphi generation stimulated by PMN-II.
  • To elucidate the mechanism by which GL affects PMN-II-induced M2Mphi production.

Main Methods:

  • Dual-chamber transwell cultures were used to model M2Mphi generation from resident macrophages (R-Mphi) stimulated by PMN-II.
  • The effect of GL was assessed by adding it to the cultures or pre-treating PMN-II or R-Mphi with GL.
  • Levels of interleukin-10 and CCL2 produced by PMN-II were measured.

Main Results:

  • GL significantly inhibited the generation of M2Mphi from R-Mphi when co-cultured with PMN-II.
  • GL prevented M2Mphi generation even when PMN-II were pre-treated with GL.
  • GL treatment of PMN-II abolished the production of interleukin-10 and CCL2, which are crucial for M2Mphi induction.

Conclusions:

  • Glycyrrhizin effectively inhibits the generation of immunosuppressive M2Mphi induced by PMN-II in a burn injury context.
  • GL acts by suppressing the production of interleukin-10 and CCL2 by PMN-II.
  • These findings suggest GL as a potential therapeutic agent to restore immune function in burn patients.